get a key
steadybase-$ company LEGN
account_id none on file
legal_name Legend Biotech Corp
ticker LEGN
cik 1801198
domain legendbiotech.com
entry_point_account_id none on file
name Legend Biotech Corporation
exchange Nasdaq
sector Health Care
calls 3 filings 8 executives 7 family 0
why_nownone on file
calls
We will continue to prioritize disciplined expense management as we fund our operating and capital expenditures, including future innovation, until we achieve company-wide profitability, excluding foreign exchange gains and losses, which we anticipate in 2026.

Nov 12, 2025 / receipt, needs a key / Carlos Santos, CFO | earnings call 2025-11-12 | transcript 1e161f7e-571e-4fc9-8f97-4a934a6c18cb | chars 19433-19693 | segment 19

So there are multiple efforts, as you mentioned, to provide some sort of either fact light or create a fact umbrella from an academic center such as UPenn to other community hospitals that are part of that umbrella. So again, these are all efforts that will continue to bring CAR T closer to patients. Patients don't want to have to travel into the cities or the major centers for their treatment, and so this enables them to get CAR T closer to home.

Aug 11, 2025 / receipt, needs a key / James Shin, other | earnings call 2025-08-11 | transcript 7a1fc6a9-f3a1-4451-8160-7cbddea7e763 | chars 39531-39982 | segment 41

We will continue to prioritize disciplined expense management as we fund our operating and capital expenditures, including future innovation, until we achieve profitability, which we anticipate in 2026, excluding unrealized foreign exchange gains or losses.

Aug 11, 2025 / receipt, needs a key / Jessi Young, interim CFO | earnings call 2025-08-11 | transcript 7a1fc6a9-f3a1-4451-8160-7cbddea7e763 | chars 17366-17623 | segment 17

filings
Carlos Santos Garcia | 54 | Chief Financial Officer

filing / Mar 10, 2026 / receipt

Corazon D. Sanders Ph.D. | 69 | Independent Director

filing / Mar 10, 2026 / receipt

Tomas Heyman | 70 | Independent Director

filing / Mar 10, 2026 / receipt

Bilingual Accounts Payable Coordinator (Mandarin, English) | {"ats": "smartrecruiters", "city": "Piscataway", "state": "NJ", "job_id": "743999693387632", "remote": false, "category": "finance_ops", "f

company_statement / Aug 14, 2019 / receipt

Associate NGS Scientist | {"ats": "smartrecruiters", "city": "Piscataway", "state": "NJ", "job_id": "743999692562011", "remote": false, "category": "other", "function": "retail", "location": "Piscataw

company_statement / Jul 30, 2019 / receipt

Associate Research Scientist II | {"ats": "smartrecruiters", "city": "Piscataway", "state": "NJ", "job_id": "743999692462536", "remote": false, "category": "other", "function": "retail", "location": "

company_statement / Jul 29, 2019 / receipt

Research Associate II | {"ats": "smartrecruiters", "city": "Piscataway", "state": "NJ", "job_id": "743999692463191", "remote": false, "category": "other", "function": "retail", "location": "Piscataway

company_statement / Jul 29, 2019 / receipt

Senior Scientist/Principle Scientist- Cell Biology and Immunology | {"ats": "smartrecruiters", "city": "Piscataway", "state": "NJ", "job_id": "743999692463490", "remote": false, "category": "other", "

company_statement / Jul 29, 2019 / receipt

executives
Alan Bash President of Kavikti - receipt
Carlos Santos CFO - receipt
Corazon D. Sanders Ph.D. Independent Director - receipt
Jessi Young interim CFO - receipt
Tomas Heyman Independent Director - receipt
Ying Huan CEO - receipt
Ying Huang CEO - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled webcast / ir
changesnone on file
mcp_package_hint
steadybase-$